LONDON: The first COVID-19 vaccine study for pregnant women has been launched in Britain. It will assess the safety of the Pfizer-BioNTech jab in healthy pregnant women. Some 235 participants will be recruited for the study, which will take place at 11 sites across Britain. Scientists hope the assessment will provide more information on the immune response in pregnant women,